Keynote Presentation:
November 15, 9am ET / 1400 GMT
DCTs deliver big ROI: How hybrid approaches deliver measurable benefits to sponsors
Decentralized clinical trials deliver time and cost efficiencies at nearly every point of the clinical research journey. In this session, you'll learn about 14 value measures that IQVIA analysts used to showcase the positive trends and impacts seen by using a combination of DCT technologies and in-home support to streamline trial operations.
But sponsors don't have to overhaul their entire protocol to reap significant benefits. Strategic deployment of tools like eConsent and eCOA can on their own strengthen engagement, workflow efficiencies and trial outcomes, IQVIA leaders will show through case studies and more.
|
Bhausaheb Patil Senior Director, Head of Business Operations, IQVIA Decentralized Trials |
![]() |
Karen Maduschke Senior Director & General Manager, IQVIA Complete Consent |